Camille Martin

3PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 01, 2022
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer.

Ludovic Juen, Christine B Baltus, Camille Gély

|Feb 25, 2021
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model.

Ludovic Juen, Christine B Baltus, Camille Gély

|Oct 25, 2018
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.

Nicolas Aubrey, Emilie Allard-Vannier, Camille Martin

Pageof 1

Frequent Collaborators

2 joint publications

Ludovic Juen

1 joint publications

Nicolas Aubrey

1 joint publications

Emilie Allard-Vannier

1 joint publications

Cyril Colas